The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention
Authors:
Open Access
- 1 January 2024
- journal article
- review article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 20 (1) , 152-174
Abstract
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) is a crucial innate defence mechanism against viral infection in the innate immune system, as it principally induces the production of type I interferons. Immune responses and metabolic control are inextricably linked, and chronic low-grade inflammation promotes the development of metabolic diseases. The cGAS-STING pathway activated by double-stranded DNA (dsDNA), cyclic dinucleotides (CDNs), endoplasmic reticulum stress (ER stress), mitochondrial stress, and energy imbalance in metabolic cells and immune cells triggers proinflammatory responses and metabolic disorders. Abnormal overactivation of the pathway is closely associated with metabolic diseases such as obesity, nonalcoholic fatty liver disease (NAFLD), insulin resistance and cardiovascular diseases (CVDs). The interaction of cGAS-STING with other pathways, such as the nuclear factor-kappa B (NF-κB), Jun N-terminal kinase (JNK), AMP-activated protein kinase (AMPK), mammalian target of rapamycin (mTOR), autophagy, pyroptosis and insulin signalling pathways, is considered an important mechanism by which cGAS-STING regulates inflammation and metabolism. This review focuses on the link between immune responses related to the cGAS-STING pathway and metabolic diseases and cGAS-STING interaction with other pathways for mediating signal input and affecting output. Moreover, potential inhibitors of the cGAS-STING pathway and therapeutic prospects against metabolic diseases are discussed. This review provides a comprehensive perspective on the involvement of STING in immune-related metabolic diseases.Keywords
This publication has 167 references indexed in Scilit:
- An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceNature Medicine, 2013
- STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling PathwayScience Signaling, 2012
- Inflammatory links between obesity and metabolic diseaseJournal of Clinical Investigation, 2011
- Toll-like receptors: linking inflammation to metabolismTrends in Endocrinology & Metabolism, 2011
- Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune responseProceedings of the National Academy of Sciences, 2009
- Adenovirus Induction of IRF3 Occurs through a Binary Trigger Targeting Jun N-Terminal Kinase and TBK1 Kinase Cascades and Type I Interferon Autocrine SignalingJournal of Virology, 2009
- Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ϵJournal of Biological Chemistry, 2009
- TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistanceJournal of Endocrinology, 2009
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancerTrends in Molecular Medicine, 2007